Patients with LV dysfunction received guideline-directed medical therapy for heart failure and required change in the HF therapy (with the use of angiotensin receptor/neprilysin inhibitor in place of Ramipril and introduction of empagliflozin) in two patients with CMR finding of nonischemic LGE. The gene discussed is MME; the disease is heart failure.